HIMSS Launches Steve Lieber Innovator Scholarship

The Steve Lieber Innovator Scholarship, sponsored by the HIMSS Foundation, recognizes the leadership and passion for innovation in digital health technology of its namesake, HIMSS president and CEO for more than 17 years.

Applications are now open for this prestigious scholarship, designated for a student pursuing a degree from an accredited collegiate undergraduate, graduate, or doctoral academic program.

“On behalf of the HIMSS Foundation, I am honored to launch the Steve Lieber Innovator Scholarship  to celebrate Steve’s impact on health IT and confirm his confidence in the innovative spirit of the health IT community,” said Thomas M.  Leary, executive director, HIMSS Foundation.  

First Corporate Donation from Smart City Networks: The call for applications and opening of the donation portal began with the generosity of organizations like Smart City Networks; Dr. Mike Zaroukian, current HIMSS Board chair and past HIMSS North America Board chair; and many others who have contributed to the program.

“Smart City Networks and Steve Lieber share a passion for innovation,” stated Marty Rubin, Smart City Networks chief executive officer, and the scholarship’s first corporate donor. “Knowing the positive impact that Steve has made throughout his career, Smart City Networks couldn’t think of a better way to honor Steve than this scholarship program to fuel the next generation of leaders in healthcare.”

“I am honored and humbled with the announcement of the Steve Lieber Innovator Scholarship. I believe in the power of change and innovation with resources committed to make change happen. I know that future leaders in digital health who receive this scholarship will present innovative opportunities to advance better health and healthcare with the best use of IT,” said Steve Lieber, HIMSS president/CEO.

To apply for the scholarship:

Call for applications is now open and will close on September 25, with award recipients announced in December 2017. Following the award criteria, scholarship applicants must:

Apply or reference frameworks, such as the HIMSS Innovation Pathways Maturity Model or others, to a workflow redesign project that is designed to move beyond the basics;

Identify new tools, articulate tactics, and design roadmaps to simplify the adoption and scalability of new care model innovations by other organizations;

Present relevant, practical, and new innovations that will employ information technology to improve care delivery, the consumer experience or the usability of health information systems; or

Identify and highlight metrics for success in either an operations or clinical workflow improvement.

 

Learn more about additional scholarship criteria.

To contribute to the scholarship:  Interested contributors can directly donate to the Steve Lieber Innovator Scholarship.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.